Almirall · 2 months ago
EXECUTIVE DIRECTOR, PEOPLE & CULTURE – GLOBAL COMMERCIAL OPERATIONS
Almirall is a people-centric company focused on transforming the world of people with skin conditions. The Executive Director, People & Culture (P&C) – Global Commercial Operations is responsible for shaping and executing the P&C strategy, ensuring alignment with global business objectives and leading a team across major European markets.
BiotechnologyMedical DevicePharmaceutical
Responsibilities
Responsible for shaping and executing the P&C strategy for GCO
Ensuring alignment with Almirall’s global business objectives and corporate culture
Driving organizational effectiveness
Talent strategy
Cultural transformation across a complex, matrixed, and international commercial environment
Qualification
Required
Key strategic advisor to the Chief Commercial Officer and the Leadership Team of General Managers across all European Affiliates
Responsible for shaping and executing the P&C strategy for GCO
Ensuring alignment with Almirall's global business objectives and corporate culture
Reports directly to the Chief People Officer
Key member of the Global P&C Leadership Team and GCO Leadership Team
Leads a team of P&C Directors and Senior Director across major European markets and Partners
Responsible for driving organizational effectiveness, talent strategy, and cultural transformation across a complex, matrixed, and international commercial environment
Company
Almirall
Almirall is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain.
H1B Sponsorship
Almirall has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$215.25M2023-06-12Post Ipo Equity· $215.25M
2022-12-21IPO
Recent News
2025-11-10
Morningstar.com
2025-11-10
Company data provided by crunchbase